Top Ten Equity Holdings and Exposures

RNS Number : 2595U

Polar Cap Gbl Healthcare Growth&IT

05 April 2016

 

5^th April 2016

Polar Capital Global Healthcare Growth and Income Trust plc (the "Company")

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31^st March 2016 and full Portfolio listing as at 29^th February 2016 available from company's website

Polar Capital Global Healthcare Growth and Income Trust plc is pleased to announce that as at 31^st March 2016 the top ten equity holdings and the sector and geographic breakdown were as follows:

Top 10 Holdings	%
Johnson & Johnson	9.0%
Eli Lilly & Co	6.8%
AstraZeneca	6.7%
Merck & Co	6.5%
Roche	5.7%
Novartis	5.3%
Pfizer	4.9%
GlaxoSmithKline	4.7%
Astellas Pharma	3.7%
Sanofi	3.2%
Total	56.5%

Sector Exposure	%
Pharmaceuticals	66.4%
Healthcare Equipment	9.6%
Biotechnology	7.3%
Healthcare REITs	5.1%
Healthcare Facilities	3.8%
Healthcare Services	3.7%
Healthcare Supplies	1.4%
Managed Healthcare	0.9%
Environmental & Facilities Services	0.5%
Life & Health Insurance	0.5%
Healthcare Distributors	0.1%
Life Sciences Tools & Services	0.1%
Cash	0.6%
Total	100.0%

Geographic Exposure	%
United States	49.5%
United Kingdom	16.2%
Switzerland	11.6%
Japan	6.0%
France	3.2%
Israel	2.9%
Australia	2.8%
Canada	2.0%
Ireland	1.8%
India	0.8%
Italy	0.8%
Germany	0.6%
Denmark	0.5%
Belgium	0.5%
Norway	0.3%
Cash	0.6%
Total	100%

The monthly factsheet will usually be available on the Company's website on the 10^th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.com 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.

 

END

 

 

MSCDMGGDDKNGVZM